Deerfield Management Company, L.P. (Series C) Legend Biotech Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Legend Biotech Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,962,338 shares of LEGN stock, worth $89.7 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
2,962,338
Previous 2,962,338
-0.0%
Holding current value
$89.7 Million
Previous $105 Million
8.12%
% of portfolio
1.8%
Previous 2.42%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
224Shares Held
57.2MCall Options Held
231KPut Options Held
626K-
Westfield Capital Management CO LP Boston, MA6.09MShares$185 Million0.91% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$181 Million5.86% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$173 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.82MShares$116 Million3.74% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.55MShares$77.2 Million0.13% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...